Patents by Inventor Kenneth J. Doniger

Kenneth J. Doniger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9882660
    Abstract: Method, system and computer program product for providing real time detection of analyte sensor sensitivity decline is continuous glucose monitoring systems are provided.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: January 30, 2018
    Assignees: ABBOTT DIABETES CARE INC., UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. Breton, Boris P. Kovatchev, Erwin Satrya Budiman, Kenneth J. Doniger
  • Publication number: 20180008201
    Abstract: Methods and devices and systems for determining an analyte value are disclosed.
    Type: Application
    Filed: September 21, 2017
    Publication date: January 11, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Publication number: 20180000389
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Application
    Filed: August 11, 2017
    Publication date: January 4, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20170360338
    Abstract: Method and apparatus for determining and outputting projected alarms or notifications associated with anticipated hyperglycemic or hypoglycemic conditions are provided. Systems and kits employing the devices described herein executing the one or more routines described are also provided.
    Type: Application
    Filed: August 31, 2017
    Publication date: December 21, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Kenneth J. Doniger, Glenn Howard Berman, Geoffrey V. McGarraugh
  • Patent number: 9839383
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: December 12, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman, Kenneth J. Doniger, John Charles Mazza
  • Patent number: 9833181
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: December 5, 2017
    Assignee: Abbot Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Publication number: 20170340250
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: August 19, 2017
    Publication date: November 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Patent number: 9814416
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: November 14, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: 9804148
    Abstract: In particular embodiments, methods, devices and systems including calibrating analyte data associated with a monitored analyte level received from an analyte sensor based on a reference measurement, determining a lag time constant associated with the calibrated analyte data, and performing lag correction of the calibrated analyte data based on the determined time lag constant are disclosed.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Patent number: 9797880
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: October 24, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger
  • Patent number: 9770211
    Abstract: Methods and devices and systems for determining an analyte value are disclosed.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: September 26, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Patent number: 9750439
    Abstract: Method and apparatus for determining and outputting projected alarms or notifications associated with anticipated hyperglycemic or hypoglycemic conditions are provided. Systems and kits employing the devices described herein executing the one or more routines described are also provided.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: September 5, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Kenneth J. Doniger, Glenn Howard Berman, Geoffrey V. McGarraugh
  • Patent number: 9737249
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: August 22, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Patent number: 9730623
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: August 15, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20170224258
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 10, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman, Kenneth J. Doniger, John Charles Mazza
  • Publication number: 20170147769
    Abstract: Presented herein are one or more software applications to help a user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with an analyte measurement device.
    Type: Application
    Filed: February 8, 2017
    Publication date: May 25, 2017
    Inventors: Daniel M. Bernstein, Kenneth J. Doniger, Timothy C. Dunn, Gary A. Hayter, Howard Wolpert
  • Patent number: 9629578
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Grant
    Filed: March 26, 2016
    Date of Patent: April 25, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman, Kenneth J. Doniger, John Charles Mazza
  • Publication number: 20170086756
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20170049369
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Patent number: 9549694
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: January 24, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman